Patent · US Expired

Use of uridine in the pharmacological treatment of the peripheral complications of diabetes

US5190948A · kind A · utility

6Cited by

0References

1Claims

0Family size

Assignee

Polifarma S.p.A. · IT

Inventors

Mario Materazzi · Roma, IT
Vincenzo Politi · Roma, IT
Giovanni Di Stazio · Roma, IT
Giovanna De Luca · Roma, IT

Key dates

Filing date	May 22, 1991
Grant date	Mar 2, 1993
Priority date	—
Expiry date	May 22, 2011

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P27/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Uridine is used to treat the peripheral complications of diabetes, such as neuropathy, retinopathy and vasculopathy, thanks to its characteristics of promotor of glycogen endocellular biosynthesis. 40 diabetic patients were treated for six months with uridine or with placebo in a double-blind clinical teat.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.